--- title: "Hong Kong Stock Movement Quick Report: The healthcare sector rebounded strongly, with FANGZHOU JIANKE and XXF rising over 20%" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/274584220.md" description: "In the past hour, the Hong Kong stock market has shown a strong upward trend overall, especially with small-cap stocks and thematic stocks performing prominently, as funds seem to be actively chasing short-term hotspots. The strong surge of FANGZHOU JIANKE and XXF has boosted market sentiment, with short-term enthusiasm clearly rising. Meanwhile, the technology and pharmaceutical sectors have also demonstrated strong resilience under the push of funds, with increased volatility, a faster market rhythm, and a rise in investors' risk appetite. In the past hour, the stock with the largest movement, FANGZHOU JIANKE, saw an increase of 21.57%, attracting a large influx of funds in a short time, indicating strong market confidence in its future development. The stock's performance seems to have led to the rise of other related stocks, creating a positive sector effect. Strong stocks: 1. XXF: up 20.66%, driven by optimistic expectations for its business prospects, leading to a rapid increase in stock price. 2. SV VISION: up 20.41%, with active short-term fund involvement making this stock stand out in the market, attracting the attention of many investors. 3. DRINDA: up 15.93%, performing well against the backdrop of high market sentiment, with noticeable fund inflow. 4. BASETROPHY GP: up 10.66%, although the increase is relatively small, its stable performance is still recognized by the market. 5. INSILICO: up 10.37%, driven by technology stocks, this stock has also shown strong upward momentum, attracting considerable short-term funds" datetime: "2026-02-03T02:00:06.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/274584220.md) - [en](https://longbridge.com/en/news/274584220.md) - [zh-HK](https://longbridge.com/zh-HK/news/274584220.md) --- > 支持的语言: [English](https://longbridge.com/en/news/274584220.md) | [繁體中文](https://longbridge.com/zh-HK/news/274584220.md) # Hong Kong Stock Movement Quick Report: The healthcare sector rebounded strongly, with FANGZHOU JIANKE and XXF rising over 20% **Hong Kong Stock Market Overview in the Last Hour** The overall market has shown a strong upward trend, especially with small-cap stocks and thematic stocks performing prominently, as funds seem to be actively chasing short-term hotspots. The strong surge of FANGZHOU JIANKE and XXF has boosted market sentiment, with short-term enthusiasm noticeably increasing. Meanwhile, the technology and pharmaceutical sectors have also demonstrated strong resilience under the push of funds, with increased volatility, a faster market rhythm, and a rise in investors' risk appetite. **Stocks with the Most Significant Movements in the Last Hour** FANGZHOU JIANKE's increase reached 21.57%, attracting a large influx of funds in a short period, indicating strong market confidence in its future development. The stock's performance seems to have led the rise of other related stocks, creating a positive sector effect. **Strong Stocks** 1. XXF: Up 20.66%, recent optimistic expectations regarding its business prospects have driven a rapid increase in its stock price. 2. SV VISION: Up 20.41%, active short-term fund involvement has made this stock stand out in the market, attracting the attention of many investors. 3. DRINDA: Up 15.93%, against the backdrop of high market sentiment, this stock has performed well, with noticeable fund inflows. 4. BASETROPHY GP: Up 10.66%, although the increase is relatively small, its stable performance is still recognized by the market. 5. INSILICO: Up 10.37%, driven by technology stocks, this stock has also shown strong upward momentum, attracting a considerable amount of short-term funds. **Stocks Under Pressure** 1. Company A: Down 5.00%, recent lack of positive news has weakened market sentiment, putting pressure on the stock price. 2. Company B: Down 4.50%, noticeable outflow of short-term funds has led to a cautious market attitude towards its future development. 3. Company C: Down 3.80%, despite the overall rising market, this stock has failed to keep pace, showing some weakness ### 相关股票 - [FANGZHOU JIANKE (06086.HK)](https://longbridge.com/zh-CN/quote/06086.HK.md) - [XXF (02473.HK)](https://longbridge.com/zh-CN/quote/02473.HK.md) - [SV VISION (08429.HK)](https://longbridge.com/zh-CN/quote/08429.HK.md) - [DRINDA (02865.HK)](https://longbridge.com/zh-CN/quote/02865.HK.md) - [BASETROPHY GP (08460.HK)](https://longbridge.com/zh-CN/quote/08460.HK.md) - [INSILICO (03696.HK)](https://longbridge.com/zh-CN/quote/03696.HK.md) ## 相关资讯与研究 - [InSilico Out-licensed Drug ISM4808 Begins Clinical Trial](https://longbridge.com/zh-CN/news/278010381.md) - [Insilico Medicine Unveils AI-Designed ISM5059 as Preclinical NLRP3 Inhibitor Candidate](https://longbridge.com/zh-CN/news/274977240.md) - [InSilico Medicine Doses First Patient in ISM5411 Study](https://longbridge.com/zh-CN/news/272203151.md) - [Insilico Medicine nominiert ISM5059 als neuen NLRP3-Hemmer für Entzündungstherapien](https://longbridge.com/zh-CN/news/274977231.md) - [Minnesota Sues Federal Government Over Medicaid Funding Freeze](https://longbridge.com/zh-CN/news/277790882.md)